First-line R-CVP versus R-CHOP induction immunochemotherapy for indolent lymphoma with rituximab maintenance. A multicentre, phase III randomized study by the Polish Lymphoma Research Group PLRG4.
scientific article
Author/s
author: Jan Walewski, Jan Maciej Zaucha, Wojciech Jurczak, Andrzej Hellmann, Ewa Kalinka-Warzocha, Grzegorz Rymkiewicz, Ewa Paszkiewicz-Kozik, Anna Borawska, Aleksandra Butrym, Agnieszka Giza, Wanda Knopinska-Posluszny, Joanna Romejko-Jarosińska, Beata Stella-Hołowiecka
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.